Page 14 - Trials Network News Today

The race is on - IAVI Report – Vol. 24, No. 1, 2020 - IAVI. Scientists are applying decades of HIV research experience to the development of SARS-CoV-2 vaccines

Christopher C. Beyrer, MD, MPH, an internationally recognized epidemiologist who has worked on the front lines of HIV/AIDS and COVID-19 treatment and research, will be the next director of the Duke

"Daily Show" host Trevor Noah joined Fred Hutch's Drs. Rachel Issaka and Michele Andrasik for a conversation about colorectal cancer screening and improving equity in health care and research.

Fred Hutchinson Cancer Center is a unified adult cancer research and care center that is a clinically integrated part of UW Medicine

/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA...

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

In todays Research Roundup for March 21, 2022, we highlight some of the most interesting reads in global health research and development from the past week.

Three potential HIV vaccines developed by Moderna have entered clinical trials, the National Institutes of Health (NIH) has confirmed.

Phase 1 study is among first to examine mRNA technology for HIV.

The National Institute of Allergy and Infectious Diseases (NIAID) has launched Phase 1 clinical trial to evaluate experimental HIV vaccines.